CClinicalTrials.gg
CompletedNCT05446909Updated Oct 29, 2024Results posted

Preventing Cognitive Decline

An interventional study of IBMT mindfulness and health education in Cognitive Decline, sponsored by Arizona State University. Completed at 1 site in United States. Open to participants aged 40 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-29.

Sponsored by Arizona State University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Feb 2021, registered May 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Study summary

The study aims to understand the mechanisms and training effects of evidence-based body-mind training on improving cognitive performance and preventing cognitive decline.

Read the detailed description

Subjective cognitive decline (SCD), the self-reported perception of memory or cognitive problems, is a risk factor for the cognitive decline and development of Alzheimer's (AD) and often happens in midlife. Recently, few mind-body interventions have suggested promising effects in preventing cognitive decline. However, these interventions often require longer training time (months to years) to achieve modest benefits, making them less optimal for rapidly learning and achieving desirable outcomes. One mechanism for cognitive decline and AD may involve deficits in self-control networks, and autonomic nervous system (ANS) and these deficits can be ameliorated through body-mind interventions. This study aims to investigate the modulation effects of a novel body-mind intervention on SCD using an evidence-based preventive intervention - integrative body-mind training (IBMT).

02

Conditions studied

  • Cognitive Decline
03

In context

Cognitive Dysfunction

3,842 studies on the registry are indexed under Cognitive Dysfunction; 1,099 are open to participants now.

This study's enrollment of 40 is below the median of 65 across 2,807 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Arizona State University is the lead sponsor of 234 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Able to read/understand English
  • Normal performance using standardized cognitive tests
  • Self-reported decline in cognitive capacity such as memory loss
  • Eligible for non-invasive fMRI
  • Willing to be randomized
  • Free of any severe psychiatric diagnoses or medication that may affect participation

Exclusion criteria

Exclusion Criteria:

  • Medical disorders or medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females)
  • Unable to provide consent or understand study procedures due to mental illness or cognitive limitations
  • Previous meditation experiences
  • Evidence of illicit drug use
  • Participants for blood draws weigh less than 110 lbs
  • Metal or metallic materials in the body such as pacemaker
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    IBMT mindfulness

    An evidence-based preventive intervention - integrative body-mind training (IBMT) has shown positive effects in reducing stress, and improving self-control and brain plasticity related to cognitive performance. It has bodifulness and mindfulness components.

    Behavioral: IBMT mindfulness

  • Active comparator
    health education

    Health education includes health-related topics - exercise, sleep, stress management, nutrition, lifestyle

    Behavioral: health education

Interventions

  • BehavioralIBMT mindfulness

    IBMT is an effortless mindfulness technique; health education is a class including health-related topics - exercise, sleep, nutrition, lifestyle, stress management

  • Behavioralhealth education

    Health education includes health-related topics - exercise, sleep, stress management, nutrition, lifestyle

06

What researchers measure

Primary outcomes

  1. Percentage of Trials Correct On Working Memory Test

    The percentage of trials correct on N-back working memory test; higher percentage of trials correct mean a better outcome.

    Time frame: The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).

  2. Intervention Effects on Cognitive Decline

    The composite measures of cognition such as subjective cognitive decline; the minimum and maximum values (1 and 27); higher scores mean a worse outcome.

    Time frame: The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).

  3. Intervention Effects on Emotion Regulation

    The composite measures of executive function such as emotion regulation questionnaire; the minimum and maximum values (4 and 10); higher scores mean a better outcome.

    Time frame: The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).

  4. Intervention Effects on Mindfulness

    The composite measures of executive function such as Five Facet Mindfulness Questionnaire; the minimum and maximum values (1 and 5); higher scores mean a better outcome.

    Time frame: The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).

Secondary outcomes

  1. Intervention Effects on Brain Function

    Changes in the strength of brain functional connectivity were measured by functional resting-state brain imaging. Higher numerical values represent stronger connectivity/better outcomes and lower values represent weaker connectivity/worse outcomes. Arbitrary units are used and the theoretical range of the values is from 0 to 1.

    Time frame: The outcome measures are assessed in-person at baseline and post-intervention (2 weeks).

  2. Intervention Effects on Brain White Matter

    Changes in AD-signature cortical brain white matter (i.e., level of fractional anisotropy) were measured by diffusion imaging. Higher numerical values represent higher white matter integrity/better outcomes and lower values represent lower white matter integrity/worse outcomes. Arbitrary units are used and the theoretical range of the values is from 0 to 1.

    Time frame: The outcome measures are assessed in-person at baseline and post-intervention (2 weeks).

  3. Intervention Effects on Brain Grey Matter

    Changes in AD-signature cortical grey matter volume were measured by MRI structural imaging. Higher numerical values represent greater grey matter volume/better outcomes and lower values represent lower grey matter volume/worse outcomes.

    Time frame: The outcome measures are assessed in-person at baseline and post-intervention (2 weeks).

07

Results

Posted Oct 29, 2024

Participant flow

Participant flow — Overall Study
MilestoneIBMT MindfulnessHealth Education
Started2020
Completed2020
Not completed00

Outcome measures

PrimaryPercentage of Trials Correct On Working Memory Test

The percentage of trials correct on N-back working memory test; higher percentage of trials correct mean a better outcome.

Time frame:
The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).
Reported as:
Mean · percentage of correct trials
Percentage of Trials Correct On Working Memory Test
percentage of correct trialsIBMT MindfulnessHealth Education
Baseline87.69 ± 0.1591.57 ± 0.14
Post-Intervention88.01 ± 0.1691.68 ± 0.17
Statistical analysis
  • IBMT Mindfulness vs Health Education · ANOVA · p = >0.05
PrimaryIntervention Effects on Cognitive Decline

The composite measures of cognition such as subjective cognitive decline; the minimum and maximum values (1 and 27); higher scores mean a worse outcome.

Time frame:
The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).
Reported as:
Mean · score on a scale
Intervention Effects on Cognitive Decline
score on a scaleIBMT MindfulnessHealth Education
Baseline5.34 ± 1.184.96 ± 1.02
Post-Intervention5.29 ± 1.174.87 ± 1.03
Statistical analysis
  • IBMT Mindfulness vs Health Education · ANOVA · p = >0.05
PrimaryIntervention Effects on Emotion Regulation

The composite measures of executive function such as emotion regulation questionnaire; the minimum and maximum values (4 and 10); higher scores mean a better outcome.

Time frame:
The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).
Reported as:
Mean · score on a scale
Intervention Effects on Emotion Regulation
score on a scaleIBMT MindfulnessHealth Education
Baseline5.71 ± 0.835.23 ± 1.12
Post-Intervention5.50 ± 1.214.94 ± 0.84
Statistical analysis
  • IBMT Mindfulness vs Health Education · ANOVA · p = >0.05
PrimaryIntervention Effects on Mindfulness

The composite measures of executive function such as Five Facet Mindfulness Questionnaire; the minimum and maximum values (1 and 5); higher scores mean a better outcome.

Time frame:
The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).
Reported as:
Mean · score on a scale
Intervention Effects on Mindfulness
score on a scaleIBMT MindfulnessHealth Education
Baseline2.92 ± 0.292.87 ± 0.32
Post-Intervention3.92 ± 0.493.39 ± 0.50
Statistical analysis
  • IBMT Mindfulness vs Health Education · ANOVA · p = <0.05
SecondaryIntervention Effects on Brain Function

Changes in the strength of brain functional connectivity were measured by functional resting-state brain imaging. Higher numerical values represent stronger connectivity/better outcomes and lower values represent weaker connectivity/worse outcomes. Arbitrary units are used and the theoretical range of the values is from 0 to 1.

Time frame:
The outcome measures are assessed in-person at baseline and post-intervention (2 weeks).
Reported as:
Mean · arbitrary units
Intervention Effects on Brain Function
arbitrary unitsIBMT MindfulnessHealth Education
Baseline0.47 ± 0.310.51 ± 0.39
Post-intervention0.53 ± 0.330.49 ± 0.35
Statistical analysis
  • IBMT Mindfulness vs Health Education · ANOVA · p = 0.754
SecondaryIntervention Effects on Brain White Matter

Changes in AD-signature cortical brain white matter (i.e., level of fractional anisotropy) were measured by diffusion imaging. Higher numerical values represent higher white matter integrity/better outcomes and lower values represent lower white matter integrity/worse outcomes. Arbitrary units are used and the theoretical range of the values is from 0 to 1.

Time frame:
The outcome measures are assessed in-person at baseline and post-intervention (2 weeks).
Reported as:
Mean · arbitrary units
Intervention Effects on Brain White Matter
arbitrary unitsIBMT MindfulnessHealth Education
Baseline0.42 ± 0.040.39 ± 0.05
Post-intervention0.43 ± 0.040.37 ± 0.04
Statistical analysis
  • IBMT Mindfulness vs Health Education · ANOVA · p = 0.985
SecondaryIntervention Effects on Brain Grey Matter

Changes in AD-signature cortical grey matter volume were measured by MRI structural imaging. Higher numerical values represent greater grey matter volume/better outcomes and lower values represent lower grey matter volume/worse outcomes.

Time frame:
The outcome measures are assessed in-person at baseline and post-intervention (2 weeks).
Reported as:
Mean · cm^3
Intervention Effects on Brain Grey Matter
cm^3IBMT MindfulnessHealth Education
Baseline589.23 ± 69.3569.39 ± 67.32
Post-intervention570.42 ± 62.11576.87 ± 64.28
Statistical analysis
  • IBMT Mindfulness vs Health Education · ANOVA · p = 0.877

Adverse events

Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
IBMT Mindfulness0/20 (0%)0/20 (0%)0/20 (0%)
Health Education0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)IBMT MindfulnessHealth EducationTotal
<=18 years000
Between 18 and 65 years202040
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)IBMT MindfulnessHealth EducationTotal
Female181735
Male235
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)IBMT MindfulnessHealth EducationTotal
Hispanic or Latino213
Not Hispanic or Latino181937
Unknown/Not Reported Ethnicity000
08

Study locations

1 site
  • Arizona State University
    Phoenix, Arizona 85004, United States
09

References and documents

Study documents

  • Protocol, analysis plan and consent form · Jun 22, 2022

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05446909
Lead sponsor
Arizona State University
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Responsible party
Sponsor
First posted
Jul 7, 2022
Start date
Feb 1, 2021
Primary completion
Feb 28, 2023
Completion
Feb 28, 2023
Results posted
Oct 29, 2024
Last update
Oct 29, 2024

Study contacts

YiYuan Tang
principal investigator · Arizona State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion